We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Update of cardiovascular disease (CVD) data looking at heart disease, diabetes, kidney disease and stroke.
Update of cardiovascular disease (CVD) profile indicators for heart disease, diabetes, kidney disease and stroke data for commissioning organisations.
Projects granted during 2015 that have a primary purpose of translational and applied research: cardiovascular disorders.
Update of cardiovascular disease (CVD) profile indicators for stroke data for clinical commissioning groups.
Caution is required if prescribing febuxostat in patients with pre-existing major cardiovascular disease, particularly, in those with evidence of high urate crystal and tophi burden or those initiating urate-lowering therapy.
This publication brings together Public Health England's (PHE’s) broad-ranging work in addressing cardiovascular disease.
Update of information on diabetes in the cardiovascular disease (CVD) profiles.
Evidence and guidance to help healthcare professionals to prevent heart attacks, strokes and dementia and to improve cardiovascular health.
These reports assess cardiovascular disease in the south-west, focusing on risk factors, heart disease, stroke, kidney disease and diabetes.
Projects granted during 2014 that have a primary purpose of basic research into the cardiovascular, blood and lymphatic system.
Overview of the UK's cardiovascular disease research infrastructure and advantage of investment in the UK's life science sector to support new treatments.
Sets out Public Health England's (PHE) initiatives for cardiovascular disease (CVD) prevention.
The outcomes versus expenditure tool shows the relationship between spending on cardiovascular disease (CVD) care and clinical outcomes.
Projects granted during 2015 that have a primary purpose of basic research: cardiovascular, blood and lymphatic system.
Cardiovascular diseases (CVDs) are one of the leading causes of death and disability in the world
This study aims to estimate the costs of Cardiovascular Disease and the costs of Diabetes Mellitus to individuals and society
Cardiovascular disease (CVD) is a major cause of death in China
This study assesses if a cardiovascular disease care package was associated with improved lifestyle and biomedical indicators
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.